Effect of rivaroxaban on circadian rhythm in healthy volunteers

Trial Profile

Effect of rivaroxaban on circadian rhythm in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Acute coronary syndromes; Atrial fibrillation; Cardiovascular disorders; Deep vein thrombosis; Embolism; Peripheral arterial disorders; Pulmonary embolism; Stroke; Thrombosis; Venous thromboembolism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Dec 2015 New trial record
    • 08 Dec 2015 Results published in the Journal of Thrombosis and Haemostasis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top